← Eichor
Study identifier: NCT05612022 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Acoustic Analysis of VA Sounds

Condition: End Stage Renal Disease · Hemodialysis Access Failure  ·  Sponsor: Mario Negri Institute for Pharmacological Research

PhaseN/A
Planned participants44
Who can joinAll sexes, 18 Years to 90 Years
Healthy volunteersNo

About this study

End-stage renal disease (ESRD) is a growing global health problem, strictly connected with progressive ageing population and longer survival of patients living on renal replacement therapy. The majority of ESRD patients is on hemodialysis (HD) treatment. A successful HD procedure requires a functioning vascular access (VA) to provide safe and long-lasting way to connect patient circulation to the artificial kidney. The current recommendation for VA is the native arteriovenous fistula (AVF), surgically created in the forearm by an anastomosis between a vein and an artery. The AVF, despite being the first-choice treatment, is still affected by high non-maturation and early failure rates, requiring in most of the cases, the creation of a new VA. An arteriovenous graft (AVG) is the second choice for a VA. Surgery is done using an artificial plastic tube that connects an artery to a vein. The AVG matures earlier than AVF (2/3 vs 6 weeks), but it is more prone to infections and has lower survival. It would be important to identify patients at risk of VA failure, but there is currently a lack of adequate strategies for surveillance. A continuous monitoring of the VA function would help in identification of reduced blood flow and VA stenosis, that could be treated by interventional radiologists before AVF or AVG complete closure. Over the years, nurses and nephrologists got used to touch the VA and qualitatively evaluate its vibration, named "thrill", and the sounds emitted by the s…

This description comes directly from the study's public registry record.

Talk to the study team

Anna Caroli  ·  003903545351  ·  anna.caroli@marionegri.it

Sofia Poloni  ·  003903545351  ·  sofia.poloni@marionegri.it

Always discuss trial participation with your own doctor first.

Locations (1)

ASST HPG23 Unità di Nefrologia e DialisiBergamo, BG, ItalyRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05612022